Signed Consignment Production Contract for Tech Transfer Raw Material Drugs, 2.4B KRW
-
Contract signed: Consignment production of raw material drugs based on technology transfer (Work Order basis)
-
Contract amount: 2,400,544,888 KRW (USD 1,609,160 at 1,491.80 KRW/USD)
-
Represents 19.15% of recent sales (as of June 2025 individual financial statements)
-
Contract period: 2026-05-14 to 2027-03-31
-
Payment: 30% on signing, 70% on completion
-
Counterparty and region: undisclosed for confidentiality
KOSDAQ Filing Information
-
Filing: Conclusion of a Single Sales and Supply Contract
-
Company: Prestige Biologics (334970)
-
Submission: Prestige Biologics Co., Ltd.
-
Receipt: 05-15-2026
-
Under KRX KOSDAQ Market Division